API
Click for more information
0.00% $1.53 australian pharmaceutical industries limited

bell potter rates her as a sell

  1. fluffynymph
    56,554 Posts.
    lightbulb Created with Sketch. 259
    clock Created with Sketch.
    01/10/06
    12:22
    Post #: 1825450
    Tepid earnings growth, the mislaid $17.2m; cited that takeover rumours pushed her up recently; finally, they rate the stock as being "expensive". FYI.
    API Price at posting: 0.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

ABY Adore Beauty appoints former David Jones exec as new CEO
right-arrow Created with Sketch.
IDA Indiana Resources to win US$90M from Tanzania following international lawsuit
right-arrow Created with Sketch.
ARU Arafura updates gas supply agreement with Mereenie JV for 16.4PJ supply to Nolans REE play
right-arrow Created with Sketch.
NEWS Super PITch gold sponsor RSM Australia: Can Diggers & Dealers 2024 be key to reinvigorating IPO activity?
right-arrow Created with Sketch.
MTL Mantle Minerals' Nick Poll talks to HotCopper on finding gold grades up to 3.57g/t at Mt Berghaus
right-arrow Created with Sketch.
DEG De Grey sees more production at Hemi with latest drilling at Crow, Aquila
right-arrow Created with Sketch.
watchlist Created with Sketch. Add API (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.